Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | -4.680% | -19.987% | 1.313% | 282.226% | 177.953% | 851.449% | 644.143% |
Geron Corp. | -4.850% | -2.006% | 8.160% | 43.413% | 113.516% | 300.190% | 304.194% |
Savara Inc. | 0.470% | 1.923% | 3.922% | 31.677% | -1.852% | 296.262% | 86.620% |
Ardelyx Inc. | 7.540% | 7.309% | 12.851% | 50.407% | -3.979% | 293.617% | 152.790% |
Eli Lilly Corp. | -4.160% | -0.607% | -12.678% | 77.419% | 39.583% | 254.497% | 628.117% |
Madrigal Pharmaceuticals inc. | -4.910% | -3.704% | -0.316% | 39.145% | 19.300% | 245.479% | 230.494% |
Insmed Inc. | 1.480% | 0.735% | 11.382% | 244.221% | 139.510% | 242.500% | 340.741% |
Catalyst Pharmaceutical Partners Inc | -5.800% | -6.823% | 2.548% | 22.484% | -2.896% | 203.317% | 230.342% |
Voyager Therapeutics Inc | -6.860% | -1.470% | 13.791% | -2.485% | 1.195% | 188.558% | -59.504% |
Vertex Pharmaceuticals Inc. | -3.260% | -0.679% | 2.766% | 38.276% | 21.943% | 171.247% | 182.297% |
Intra-Cellular Therapies Inc. | -4.080% | -4.698% | 10.938% | 28.623% | 8.896% | 141.414% | 852.892% |
Medpace Holdings Inc | -5.070% | -1.763% | -8.112% | 47.966% | 22.954% | 133.446% | 388.615% |
Sarepta Therapeutics | 0.530% | -1.874% | -6.969% | 38.831% | 50.882% | 130.969% | 1.505% |
Cytokinetics Inc. | -4.630% | -4.545% | 2.941% | 83.566% | -31.373% | 115.164% | 378.840% |
Regeneron Pharmaceuticals Inc. | -1.920% | -0.242% | 1.955% | 48.021% | 24.263% | 103.784% | 260.692% |
Ani Pharmaceuticals Inc. | -6.720% | -1.754% | -5.085% | 19.658% | 12.450% | 101.439% | -26.190% |
Corcept Therapeutics Inc. | -2.180% | 7.287% | 15.604% | 51.681% | 17.300% | 101.086% | 212.856% |
United Therapeutics | -2.730% | -3.191% | 1.762% | 36.438% | 51.475% | 93.742% | 320.235% |
Axsome Therapeutics Inc | -3.580% | -2.963% | 5.285% | 15.373% | 7.540% | 82.483% | 235.795% |
Neurocrine Bioscience | -1.520% | 3.811% | 9.652% | 48.970% | 17.603% | 79.458% | 65.800% |
AbbVie Inc. | -1.490% | 1.689% | 12.288% | 27.062% | 23.797% | 78.344% | 193.966% |